Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the recombinant proteins market right now?

The market size of recombinant proteins has witnessed a significant growth in recent times. It is set to increase from $2.31 billion in 2024 to $2.57 billion in 2025, with a compound annual growth rate (CAGR) of 11.3%. The factors contributing to this historic period growth include the rising demand for biopharmaceuticals, an increase in chronic diseases, an ageing population, initiatives and financial support from the government, and a widening scope in research and diagnostic applications.

How fast Is the recombinant proteins market expected to grow, and what’s its future value?

Expectations point towards a swift expansion in the size of the recombinant proteins market in the upcoming years, with it projected to reach a value of $4.3 billion in 2029, growing at a compound annual growth rate (CAGR) of 13.7%. The predicted growth is likely due to factors such as the rising acceptance of personalized medicine, fast-paced growth of the biotechnology sector, global initiatives to tackle rare diseases, progress in protein engineering techniques, the rise of emerging markets, and unexplored opportunities. Key trends for the forecast period are the progression of personalized medicine, accelerated growth in biotechnology, increased demand for therapeutic proteins, the advent of new therapeutic targets, and a worldwide emphasis on vaccine development.

Get your recombinant proteins market report here!

https://www.thebusinessresearchcompany.com/report/recombinant-proteins-global-market-report

What are the leading drivers of growth in the recombinant proteins market?

The expansion of the recombinant protein market is anticipated to be driven by the increasing emphasis on personalized medicine. This healthcare approach customizes treatments and therapies to align with an individual’s specific genetics, characteristics, and needs, aiming for more targeted and efficient healthcare outcomes. Genomic technologies and data analytics advances are the key contributors to the rise in personalized medicine. They facilitate tailored treatments based on a person’s genetic details. With the use of recombinant proteins, personalized medicine can be enhanced by creating specialized therapies that target a person’s distinctive genetic and molecular structure. This helps improve the effectiveness of the treatment and minimize side effects. For example, according to the Personalized Medicine Coalition, a non-profit organization based in the US, the FDA authorized 16 new personalized treatments in 2023 for patients suffering from rare diseases. This was a remarkable leap from the six approved in 2022. Hence, the increased interest in personalized medicine is propelling the growth of the recombinant protein market.

What are the key segments defining the recombinant proteins market?

The recombinant proteins market covered in this report is segmented –

1) By Product: Antibodies, Cytokines, Immune Checkpoint Protein, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones, Other Products

2) By Application: Drug And Discovery Development, Therapeutics, Research, Other Applications

3) By End User: Pharmaceutical And Biotechnology Companies, Academic And Research Institute, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Antibodies: Monoclonal Antibodies, Polyclonal Antibodies

2) By Cytokines: Interleukins, Interferons, Tumor Necrosis Factors (TNFs)

3) By Immune Checkpoint Proteins: PD-1 Or PD-L1 Inhibitors, CTLA-4 Inhibitors

4) By Virus Antigens: Viral Capsid Proteins, Envelope Proteins

5) By Enzymes: Restriction Enzymes, Polymerases, Ligases

6) By Recombinant Regulatory Proteins: Transcription Factors, Receptors, Hormones

7) By Hormones: Insulin, Growth Hormones

8) By Other Products: Fusion Proteins, Peptide Therapeutics

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9959&type=smp

Who are the key players steering the development of the recombinant proteins market?

Major companies operating in the recombinant proteins market include Abcam plc, Abnova Corporation, Bio-Rad Laboratoroies Inc., Merck Co. & KGaA, R&D Systems Inc., Proteintech Group Inc., RayBiotech Life Inc., GenScript Biotech Corporation, Elpiscience Biopharmaceuticals Co. Ltd., Elevian Inc., Gigagen Inc., Janssen- Cilag Pvt. Ltd., Sino Biological Inc., OriGene Technologies Inc., Feldan Therapeutics Inc., Randox Laboratories Ltd., Bio-Techne Corporation, Thermo Fisher Scientific Inc., PerkinElmer Inc., Crown Bioscience Inc., Airway Therapeutics Inc., Amgen Inc., Aviva Systems Biology Corp., Eli Lilly and Company

What emerging trends are influencing the growth of the recombinant proteins market?

Advancements in product innovation are a growing trend within the recombinant protein market. To fortify their standing in this market, leading companies are concentrating their efforts on creating novel products. A case in point would be the introduction of the XtenCHO Transient CHO Expression System by ProteoGenix, a biochemistry company based in France in March 2022. This system, launched with a view to enhance biologics development, presents numerous benefits such as tenfold higher yields, enhanced plasmid stability, and sophisticated protocols that require less manual intervention. The XtenCHO system is fast-track and cost-efficient, making it superbly suited for drug development and various bioanalytical operations.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9959

Which regions are most influential in expanding the recombinant proteins market?

North America was the largest region in the recombinant protein market in 2024. The regions covered in the recombinant proteins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Hair Color Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hair-color-global-market-report

Hair Preparations Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hair-preparations-global-market-report

Natural Hair Care Products Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/natural-hair-care-products-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: